Investors Can Lead GPGI Securities Fraud Lawsuit
Rosen Law Firm reminds GPGI, Inc. (formerly CompoSecure) stockholders of a deadline to join a securities fraud lawsuit concerning alleged false and misleading statements.
Investors have an opportunity to serve as lead plaintiff in a securities fraud lawsuit concerning GPGI, Inc. f/k/a CompoSecure, Inc. Rosen Law Firm, a global investor rights law firm, has urged purchasers of the company's Class A common stock between November 3, 2025, and May 6, 2026, inclusive, to consider seeking lead plaintiff status.
Kan Delaney of Rosen Law Firm stated that the deadline to file a lead plaintiff motion is approaching. The lawsuit alleges that GPGI, Inc. and certain of its officers made potentially significant false or misleading statements during the class period. The company was formerly known as CompoSecure, Inc.
The litigation focuses on allegations that the company made materially false or misleading statements regarding its business and operations. Investors who purchased GPGI, Inc. securities during the specified period are encouraged to contact Rosen Law Firm to learn more about their rights and the upcoming deadline.
Delaney added that the lawsuit seeks to recover damages for investors who have suffered losses as a result of the alleged misrepresentations. Further details are available on the Rosen Law Firm website.